GoHealth (NASDAQ:GOCO - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $2.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.16 by $1.25, Zacks reports. GoHealth had a negative net margin of 4.32% and a negative return on equity of 17.17%. The firm had revenue of $389.13 million for the quarter, compared to the consensus estimate of $326.56 million.
GoHealth Price Performance
Shares of NASDAQ:GOCO traded down $0.08 during trading on Monday, reaching $14.41. 59,364 shares of the company's stock traded hands, compared to its average volume of 65,167. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. GoHealth has a fifty-two week low of $7.27 and a fifty-two week high of $21.00. The company has a 50-day simple moving average of $15.63 and a 200-day simple moving average of $12.17. The firm has a market cap of $330.08 million, a PE ratio of -4.12 and a beta of 1.67.
Hedge Funds Weigh In On GoHealth
A hedge fund recently raised its stake in GoHealth stock. Bank of America Corp DE grew its holdings in GoHealth, Inc. (NASDAQ:GOCO - Free Report) by 22.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,831 shares of the company's stock after buying an additional 1,452 shares during the quarter. Bank of America Corp DE's holdings in GoHealth were worth $105,000 as of its most recent SEC filing. 24.21% of the stock is owned by institutional investors and hedge funds.
GoHealth Company Profile
(
Get Free Report)
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Read More
Before you consider GoHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.
While GoHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
